Applicable pharmacokinetic study: Development and validation of bioanalytical LC-MS/MS method for the simultaneous quantification of cytarabine and glasdegib used for the treatment of acute myeloid leukemia

[1]  A. El-Azab,et al.  A Liquid Chromatography Tandem Mass Spectrometry Method for the Simultaneous Estimation of the Dopamine Receptor Antagonist LE300 and Its N-methyl Metabolite in Plasma: Application to a Pharmacokinetic Study , 2023, Molecules.

[2]  A. Kadi,et al.  Effective quantification of ravidasvir (an NS5A inhibitor) and sofosbuvir in rat plasma by validated LC-MS/MS method and its application to pharmacokinetic study , 2020 .

[3]  J. Masters,et al.  Clinical and Model‐Based Evaluation of the Effect of Glasdegib on Cardiac Repolarization From a Randomized Thorough QT Study , 2020, Clinical pharmacology in drug development.

[4]  L. Mayer,et al.  Pharmacokinetics, drug metabolism, and tissue distribution of CPX-351 in animals. , 2020, Nanomedicine : nanotechnology, biology, and medicine.

[5]  H. Alkahtani,et al.  Development and validation of an UHPLC-MS/MS method for simultaneous determination of palbociclib, letrozole and its metabolite carbinol in rat plasma and pharmacokinetic study application , 2020 .

[6]  R. Labadie,et al.  Absolute Oral Bioavailability of Glasdegib (PF‐04449913), a Smoothened Inhibitor, in Randomized Healthy Volunteers , 2019, Clinical pharmacology in drug development.

[7]  T. Naoe,et al.  Small‐molecule Hedgehog inhibitor attenuates the leukemia‐initiation potential of acute myeloid leukemia cells , 2016, Cancer science.

[8]  M. Bornhäuser,et al.  Simultaneous determination of clofarabine and cytarabine in human plasma by LC-MS/MS. , 2016, Journal of pharmaceutical and biomedical analysis.

[9]  Shery Jacob,et al.  A simple practice guide for dose conversion between animals and human , 2016, Journal of basic and clinical pharmacy.

[10]  Q. Xiao,et al.  HPLC-MS/MS method for the simultaneous determination of MB07133 and its metabolites, cytarabine and arabinofuranosyluracil, in rat plasma. , 2016, Journal of pharmaceutical and biomedical analysis.

[11]  Richard A. Moore,et al.  GLI2 inhibition abrogates human leukemia stem cell dormancy , 2015, Journal of Translational Medicine.

[12]  K. Wagner,et al.  Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects , 2015, Clinical Cancer Research.

[13]  S. Armstrong,et al.  Evolutionarily Conserved Signaling Pathways: Acting in the Shadows of Acute Myelogenous Leukemia's Genetic Diversity , 2015, Clinical Cancer Research.

[14]  A. Rao,et al.  Acute myeloid leukemia and myelodysplastic syndromes in older adults. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Copland,et al.  Targeting hedgehog in hematologic malignancy. , 2012, Blood.

[16]  N. C. van de Merbel,et al.  HPLC-MS/MS method for the determination of cytarabine in human plasma. , 2011, Bioanalysis.

[17]  M. Peppelenbosch,et al.  Hedgehog signaling maintains chemoresistance in myeloid leukemic cells , 2010, Oncogene.

[18]  Yong Zhang,et al.  PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel , 2010, Comput. Methods Programs Biomed..

[19]  Yongbing Sun,et al.  High-performance liquid chromatography/tandem mass spectrometry method for the simultaneous determination of cytarabine and its valyl prodrug valcytarabine in rat plasma. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  Ming Liu,et al.  A mixed-mode liquid chromatography-tandem mass spectrometric method for the determination of cytarabine in mouse plasma. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[21]  Hyo-Kyung Han,et al.  Pharmacokinetic characteristics of L-valyl-ara-C and its implication on the oral delivery of ara-C , 2007, Acta Pharmacologica Sinica.

[22]  Rajesh R. Singh,et al.  Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms. , 2012, The American journal of pathology.